Safety and acute efficacy of catheter ablation for atrial fibrillation with pulsed field ablation vs thermal energy ablation: A meta-analysis of single proportions.

Atrial fibrillation Meta-analysis Pulsed field ablation Safety Thermal ablation

Journal

Heart rhythm O2
ISSN: 2666-5018
Titre abrégé: Heart Rhythm O2
Pays: United States
ID NLM: 101768511

Informations de publication

Date de publication:
Oct 2023
Historique:
medline: 8 11 2023
pubmed: 8 11 2023
entrez: 8 11 2023
Statut: epublish

Résumé

Pulsed field ablation (PFA) has emerged as a novel energy source for the ablation of atrial fibrillation (AF) using ultrarapid electrical pulses to induce cell death via electroporation. The purpose of this study was to compare the safety and acute efficacy of ablation for AF with PFA vs thermal energy sources. We performed an extensive literature search and systematic review of studies that evaluated the safety and efficacy of ablation for AF with PFA and compared them to landmark clinical trials for ablation of AF with thermal energy sources. Freeman-Tukey double arcsine transformation was used to establish variance of raw proportions followed by the inverse with the random-effects model to combine the transformed proportions and generate the pooled prevalence and 95% confidence interval (CI). We included 24 studies for a total of 5203 patients who underwent AF ablation. Among these patients, 54.6% (n = 2842) underwent PFA and 45.4% (n = 2361) underwent thermal ablation. There were significantly fewer periprocedural complications in the PFA group (2.05%; 95% CI 0.94-3.46) compared to the thermal ablation group (7.75%; 95% CI 5.40-10.47) ( Based on the results of this meta-analysis, PFA was associated with lower rates of periprocedural complications and similar rates of acute procedural success and recurrent AF with up to 1 year of follow-up compared to ablation with thermal energy sources.

Sections du résumé

Background UNASSIGNED
Pulsed field ablation (PFA) has emerged as a novel energy source for the ablation of atrial fibrillation (AF) using ultrarapid electrical pulses to induce cell death via electroporation.
Objective UNASSIGNED
The purpose of this study was to compare the safety and acute efficacy of ablation for AF with PFA vs thermal energy sources.
Methods UNASSIGNED
We performed an extensive literature search and systematic review of studies that evaluated the safety and efficacy of ablation for AF with PFA and compared them to landmark clinical trials for ablation of AF with thermal energy sources. Freeman-Tukey double arcsine transformation was used to establish variance of raw proportions followed by the inverse with the random-effects model to combine the transformed proportions and generate the pooled prevalence and 95% confidence interval (CI).
Results UNASSIGNED
We included 24 studies for a total of 5203 patients who underwent AF ablation. Among these patients, 54.6% (n = 2842) underwent PFA and 45.4% (n = 2361) underwent thermal ablation. There were significantly fewer periprocedural complications in the PFA group (2.05%; 95% CI 0.94-3.46) compared to the thermal ablation group (7.75%; 95% CI 5.40-10.47) (
Conclusion UNASSIGNED
Based on the results of this meta-analysis, PFA was associated with lower rates of periprocedural complications and similar rates of acute procedural success and recurrent AF with up to 1 year of follow-up compared to ablation with thermal energy sources.

Identifiants

pubmed: 37936671
doi: 10.1016/j.hroo.2023.09.003
pii: S2666-5018(23)00222-2
pmc: PMC10626185
doi:

Types de publication

Journal Article

Langues

eng

Pagination

599-608

Informations de copyright

© 2023 Heart Rhythm Society. Published by Elsevier Inc.

Références

Circ Arrhythm Electrophysiol. 2020 Jun;13(6):e008718
pubmed: 32383391
Circulation. 2011 Nov 15;124(20):2264-74
pubmed: 22083148
JAMA. 2014 Feb 19;311(7):692-700
pubmed: 24549549
Eur J Clin Invest. 2019 Nov;49(11):e13174
pubmed: 31560809
N Engl J Med. 2012 Oct 25;367(17):1587-95
pubmed: 23094720
Ann Biomed Eng. 2005 Feb;33(2):223-31
pubmed: 15771276
Circ Arrhythm Electrophysiol. 2013 Dec;6(6):1082-8
pubmed: 24243785
Heart Rhythm. 2015 Aug;12(8):1838-44
pubmed: 25998897
Europace. 2021 Nov 8;23(11):1767-1776
pubmed: 34240134
J Interv Card Electrophysiol. 2019 Sep;55(3):251-265
pubmed: 31270656
Europace. 2022 Jul 21;24(7):1084-1092
pubmed: 35513354
J Cardiovasc Electrophysiol. 2022 Mar;33(3):345-356
pubmed: 34978360
N Engl J Med. 2021 Jan 28;384(4):316-324
pubmed: 33197158
Circulation. 2023 May 9;147(19):1422-1432
pubmed: 36877118
Europace. 2013 Jan;15(1):144-9
pubmed: 22654094
IEEE Trans Biomed Eng. 2006 Jul;53(7):1409-15
pubmed: 16830945
Ann Intern Med. 2009 Aug 18;151(4):W65-94
pubmed: 19622512
Europace. 2022 Sep 1;24(8):1256-1266
pubmed: 35647644
N Engl J Med. 2021 Jan 28;384(4):305-315
pubmed: 33197159
Circulation. 2022 Dec 13;146(24):1808-1819
pubmed: 36134574
Circ Arrhythm Electrophysiol. 2017 May;10(5):
pubmed: 28487347
Circ Arrhythm Electrophysiol. 2022 Jan;15(1):e010168
pubmed: 34964367
JAMA. 2005 Jun 1;293(21):2634-40
pubmed: 15928285
Circ Arrhythm Electrophysiol. 2014 Aug;7(4):734-8
pubmed: 24958397
J Am Coll Cardiol. 2020 Sep 1;76(9):1068-1080
pubmed: 32854842
Cancer Res. 2012 Mar 15;72(6):1336-41
pubmed: 22282658
Technol Cancer Res Treat. 2007 Feb;6(1):37-48
pubmed: 17241099
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
J Am Coll Cardiol. 2019 Jul 23;74(3):315-326
pubmed: 31085321
Circ Arrhythm Electrophysiol. 2020 Oct;13(10):e008192
pubmed: 32898450
N Engl J Med. 2016 Jun 9;374(23):2235-45
pubmed: 27042964
Annu Rev Biomed Eng. 2014 Jul 11;16:295-320
pubmed: 24905876
Heart Rhythm. 2021 Jun;18(6):878-884
pubmed: 33647464
J Interv Card Electrophysiol. 2023 Apr;66(3):567-575
pubmed: 36038739
Technol Cancer Res Treat. 2007 Aug;6(4):255-60
pubmed: 17668932
Clin Res Cardiol. 2023 Jun;112(6):795-806
pubmed: 36131138
JACC Clin Electrophysiol. 2021 May;7(5):614-627
pubmed: 33933412
JACC Clin Electrophysiol. 2018 Aug;4(8):987-995
pubmed: 30139499
Heart Rhythm. 2020 Nov;17(11):1841-1847
pubmed: 32590151
Europace. 2021 Sep 8;23(9):1391-1399
pubmed: 33961027
Burns. 2006 Feb;32(1):52-9
pubmed: 16384650
Circ Arrhythm Electrophysiol. 2022 Jun;15(6):e010817
pubmed: 35617232
Biophys J. 1994 Jul;67(1):42-56
pubmed: 7919016
JAMA. 2019 Apr 2;321(13):1261-1274
pubmed: 30874766
J Am Coll Cardiol. 2014 Dec 2;64(21):e1-76
pubmed: 24685669

Auteurs

Omar M Aldaas (OM)

Section of Cardiac Electrophysiology, Division of Cardiology at the University of California San Diego Health System, La Jolla, California.

Chaitanya Malladi (C)

Section of Cardiac Electrophysiology, Division of Cardiology at the University of California San Diego Health System, La Jolla, California.

Amer M Aldaas (AM)

T. Still University School of Osteopathic Medicine, Mesa, Arizona.

Frederick T Han (FT)

Section of Cardiac Electrophysiology, Division of Cardiology at the University of California San Diego Health System, La Jolla, California.

Kurt S Hoffmayer (KS)

Section of Cardiac Electrophysiology, Division of Cardiology at the University of California San Diego Health System, La Jolla, California.

David Krummen (D)

Section of Cardiac Electrophysiology, Division of Cardiology at the University of California San Diego Health System, La Jolla, California.

Gordon Ho (G)

Section of Cardiac Electrophysiology, Division of Cardiology at the University of California San Diego Health System, La Jolla, California.

Farshad Raissi (F)

Section of Cardiac Electrophysiology, Division of Cardiology at the University of California San Diego Health System, La Jolla, California.

Ulrika Birgersdotter-Green (U)

Section of Cardiac Electrophysiology, Division of Cardiology at the University of California San Diego Health System, La Jolla, California.

Gregory K Feld (GK)

Section of Cardiac Electrophysiology, Division of Cardiology at the University of California San Diego Health System, La Jolla, California.

Jonathan C Hsu (JC)

Section of Cardiac Electrophysiology, Division of Cardiology at the University of California San Diego Health System, La Jolla, California.

Classifications MeSH